A mechanism of action with a mixed history but signs of promise piqued the interest of Roche AG\u2019s Genentech unit, which signed a $2.3 billion deal \u2013 pledging a humble $190 million up front \u2013 with Hanmi Pharmaceutical Co. Ltd. to develop, manufacture and commercialize worldwide the latter\u2019s metabolic treatment candidate, HM-17321. Eyed in the deal are obesity and associated conditions such as type 2 diabetes and cardiovascular (CV) diseases. The terms exclude South Korea, where Hanmi is based in Seoul.<\/p>\n
BioWorld Asia<\/a> Deals and M&A<\/a> Cardiovascular<\/a> Diabetes<\/a> Endocrine\/metabolic<\/a> Obesity<\/a> Asia-Pacific<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"A mechanism of action with a mixed history but signs of promise piqued the interest of Roche AG\u2019s…\n","protected":false},"author":2,"featured_media":126806,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[941,8086,15287,3750,8568,7250,8573,1360,61893,61894,1813,134,4178,33973,61895,61896],"class_list":["post-126805","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-asia-pacific","tag-bioworld","tag-bioworld-asia","tag-cardiovascular","tag-deals-and-ma","tag-diabetes","tag-endocrine-metabolic","tag-genentech","tag-hanmi-pharmaceutical-co-ltd","tag-hm-17321","tag-obesity","tag-roche","tag-roche-ag","tag-type-2-diabetes","tag-ucn2-analogue","tag-urocortin-2"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/117228176847988137","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/126805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=126805"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/126805\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/126806"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=126805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=126805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=126805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}